TNG:EPA
Transgene SA
0,70 €
arrow_downward
-1,82%(-0,013) 1D
2 tet, 2:29:45 m.d., GMT+2 · EUR
search
Të gjitha simbolet
| Me simbole | Çmimi | Ndrysho | % ndryshim |
|---|
insights_autoPo gjenerohen statistikat kryesore për TNG...
Hap
0,70 €
I lartë
0,70 €
I ulët
0,69 €
Kapitalizimi i tregut
195,81 mln
Vëllimi mesatar
140,11 mijë
Vëllimi
131,45 mijë
Maksimumi 52-javor
1,50 €
Minimumi 52-javor
0,69 €
Fitimet për aksion
-0,17 €
Aksionet në qarkullim
278,56 mln
Numri i punonjësve
160
Hap
0,70 €
I lartë
0,70 €
I ulët
0,69 €
Kapitalizimi i tregut
195,81 mln
Vëllimi mesatar
140,11 mijë
Vëllimi
131,45 mijë
Maksimumi 52-javor
1,50 €
Minimumi 52-javor
0,69 €
Fitimet për aksion
-0,17 €
Aksionet në qarkullim
278,56 mln
Numri i punonjësve
160
Lajmet
Nga burimet në ueb dhe partnerët e lajmeve
Business Wire
·
17 minuta më parë
Powerus Completes Merger, Rings Opening Bell, Now Trading as PUSA on Nasdaq
Simply Wall Street
·
1 orë më parë
SoundHound AI (SOUN) Brings Real Time Conversational AI To A Mass Market Vehicle
GlobeNewswire
·
1 orë më parë
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Axios
·
1 orë më parë
Bond market zig zags threaten S&P 500's smooth ride
Profili
Transgene S.A. is a French biotechnology company founded in 1979. It is based in Illkirch-Graffenstaden, near Strasbourg, Alsace. The company develops and manufactures immunotherapies for the treatment of cancer. Based on viral vectors, these therapies stimulate the immune defenses of patients to specifically target cancer cells.
Transgene has two technological platforms based on these respective approaches: individual therapeutic vaccines, shared antigens cancer vaccines oncolytic viruses.
Transgene's portfolio consists of four products currently in clinical development. Its lead product TG4050, a neoantigen individualized therapeutic cancer vaccine is currently being developed in a randomized Phase I/II trial in the adjuvant treatment of head and neck cancer.
The company is listed on the regulated market of Euronext in Paris. Wikipedia
Rreth Transgene SA